Lb Pharmaceuticals (LBRX) Current Assets (2024 - 2026)

Lb Pharmaceuticals' Current Assets history runs 3 years deep, the most recent figure standing at $389.1 million for Q1 2026.

• In Q1 2026, Current Assets changed N/A year-over-year to $389.1 million; the TTM figure through Mar 2026 stood at $389.1 million (changed N/A YoY), while the FY2025 annual figure was $308.4 million, up 968.01% from the prior year.
• Current Assets for Q1 2026 stood at $389.1 million, up from $308.4 million in the prior quarter.
• The five-year high for Current Assets was $389.1 million in Q1 2026, with the low at $28.9 million in Q4 2024.
• The 3-year median for Current Assets is $312.4 million (2025), against an average of $260.7 million.
• Peak annual rise in Current Assets reached 968.01% in 2025, while the deepest fall reached 968.01% in 2025.
• Lb Pharmaceuticals' Current Assets stood at $28.9 million in 2024, then surged by 968.01% to $308.4 million in 2025, then increased by 26.15% to $389.1 million in 2026.
• Business Quant data shows LBRX's Current Assets at $389.1 million in Q1 2026, $308.4 million in Q4 2025, and $316.4 million in Q3 2025.